You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


Immunotherapy

Citations 21-30 of 81 total displayed.

Past content (since Jan 1998):

Studies
Dosing With 5% Imiquimod Cream 3 Times per Week for the Treatment of Actinic Keratosis: Results of Two Phase 3, Randomized, Double-blind, Parallel-Group, Vehicle-Controlled Trials
Neil Korman; Ron Moy; Mark Ling; Robert Matheson; Stacy Smith; Scott McKane; James H. Lee
Arch Dermatol 2005; 141: 467-473. [Abstract] [Full text] [PDF]  

Observations
Treatment of Lentigo Maligna (Melanoma In Situ) With the Immune Response Modifier Imiquimod
Ingrid H. Wolf; Lorenzo Cerroni; Kazuo Kodama; Helmut Kerl
Arch Dermatol 2005; 141: 510-514. [Abstract] [Full text] [PDF]  

Studies
Topical Tacrolimus Ointment Combined With 6% Salicylic Acid Gel for Plaque Psoriasis Treatment
Christie L. Carroll; Jan Clarke; Fabian Camacho; Rajesh Balkrishnan; Steven R. Feldman
Arch Dermatol 2005; 141: 43-46. [Abstract] [Full text] [PDF]  

Observations
Psoriasis Triggered by Toll-like Receptor 7 Agonist Imiquimod in the Presence of Dermal Plasmacytoid Dendritic Cell Precursors
Michel Gilliet; Curdin Conrad; Michael Geiges; Antonio Cozzio; Wolfgang Thürlimann; Günter Burg; Frank O. Nestle; Reinhard Dummer
Arch Dermatol 2004; 140: 1490-1495. [Abstract] [Full text] [PDF]  

Observations
Response of Oral Lichen Planus to Topical Tacrolimus in 37 Patients
Julie A. Byrd; Mark D. P. Davis; Alison J. Bruce; Lisa A. Drage; Roy S. Rogers III
Arch Dermatol 2004; 140: 1508-1512. [Abstract] [Full text] [PDF]  

Evidence-Based Dermatology: Studies
Statistical Significance and Clinical Relevance: The Importance of Power in Clinical Trials in Dermatology
Sachin S. Bhardwaj; Fabian Camacho; Amy Derrow; Alan B. Fleischer Jr; Steven R. Feldman
Arch Dermatol 2004; 140: 1520-1523. [Abstract] [Full text] [PDF]  

Correspondence
Low Incidence of New Actinic Keratoses After Topical 5% Imiquimod Cream Treatment: A Long-term Follow-up Study
Eggert Stockfleth; Enno Christophers; Bernd Benninghoff; Wolfram Sterry
Arch Dermatol 2004; 140: 1542. [Extract] [Full text] [PDF]  

Studies
Treatment of Undifferentiated Vulvar Intraepithelial Neoplasia With 5% Imiquimod Cream: A Prospective Study of 12 Cases
Jeanne Wendling; Philippe Saiag; Sophie Berville-Levy; Isabelle Bourgault-Villada; Thierry Clerici; Micheline Moyal-Barracco
Arch Dermatol 2004; 140: 1220-1224. [Abstract] [Full text] [PDF]  

Correspondence
Sentinel Lymph Node Biopsy for High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck
Keyvan Nouri; Maria Patricia Rivas; Felipe Pedroso; Rita Bhatia; Francisco Civantos
Arch Dermatol 2004; 140: 1284. [Extract] [Full text] [PDF]  

Correspondence
5% Imiquimod Cream for the Treatment of Large Superficial Basal Cell Carcinoma
Stephen Shumack; Kurt Gebauer; Chris Quirk; Ken Macdonald; Shelley-Ann Walters; Mary Owens
Arch Dermatol 2004; 140: 1286-1287. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9

 Collections
 •Sign up for Topic Collection Alerts
 •Topic Collections Home
 • Show Immunotherapy
 collections from JAMA & Archives Journals.
 •Related collections:
  •Dermatologic Procedures
  •Dermatologic Laser Surgery
  •Dermatologic Surgery
  •Immunotherapy
  •Phototherapy
  •Dermatologic Procedures, Other
Advertisement





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.